Raphael Pharmaceutical Inc. (CIK: 0001415397) EDGAR, Information, Filings... CompaniesBIO.Com

Raphael Pharmaceutical Inc.

Mailing address
SUITE 105 - 5348 VEGAS DR., LAS VEGAS, Nevada, 89108
Phone
702-442-1166
State location
Nevada
State of incorporation
Nevada
Fiscal year end
December 31
SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Filings
N/A

Raphael Pharmaceutical Inc. (CIK: 0001415397) is an American company incorporated in the state of Nevada. Head office is located at SUITE 105 - 5348 VEGAS DR., LAS VEGAS, Nevada, 89108. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. Raphael Pharmaceutical Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Easy Energy Inc from 2007-24-Oct to 2021-14-May

Owner	Filings	Transaction Date	Type of Owner
Press Joseph	0001903092	Sep-27-2021	director
Pilo Shlomo	0001903730	Sep-27-2021	director, 10 percent owner, officer: Chief Executive Officer
Louria Hayon Igal	0001903781	Sep-27-2021	director, officer: Chief Technology Officer
Eliya Yehuda	0001904163	Sep-27-2021	director
CATELL ROBERT B	0001195325	Sep-30-2010	director
Yanay Elisha	0001402863	Sep-30-2010	director
SHAMASH YACOV A	0001013589	Jul-23-2010	director
Ofir Guy	0001424145	Dec-18-2007	director, 10 percent owner, officer: President
Cohen Emanuel	0001424146	Dec-18-2007	director, 10 percent owner, officer: Secretary Treasurer Director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Raphael Pharmaceutical Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-25-109968 (34 Act) Size: KB	Nov-13-2025	000-53002 251478196
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-25-085537 ( Act) Size: 0 KB	Sep-08-2025
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-25-075662 (34 Act) Size: KB	Aug-13-2025	000-53002 251211547
8-K	Document	Current report filing Acc-no: 0001213900-25-074293 (34 Act) Size: KB	Aug-11-2025	000-53002 251201970
8-K	Document	Current report filing Acc-no: 0001213900-25-073909 (34 Act) Size: KB	Aug-11-2025	000-53002 251200097
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-25-043641 (34 Act) Size: KB	May-15-2025	000-53002 25948444
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-25-026214 (34 Act) Size: KB	Mar-31-2025	000-53002 25792986
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-023367 ( Act) Size: 0 KB	Mar-12-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-022736 ( Act) Size: 0 KB	Mar-11-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-25-021172 ( Act) Size: 0 KB	Mar-06-2025
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001213900-25-013687 ( Act) Size: 0 KB	Feb-13-2025
8-K	Document	Current report filing Acc-no: 0001213900-25-003401 (34 Act) Size: KB	Jan-14-2025	000-53002 25529356
8-K	Document	Current report filing Acc-no: 0001213900-24-113467 (34 Act) Size: KB	Dec-30-2024	000-53002 241589630
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001213900-24-100968 (33 Act) Size: KB	Nov-21-2024	333-282104 241484160
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-098456 (34 Act) Size: KB	Nov-14-2024	000-53002 241462555
EFFECT	Document	Acc-no: 9999999995-24-002976 (33 Act) Size: KB	Sep-26-2024	333-282104 241330335
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-081436 ( Act) Size: KB	Sep-24-2024
UPLOAD	Document	Acc-no: 0000000000-24-010774 ( Act) Size: KB	Sep-23-2024	333-282104
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001213900-24-078562 (33 Act) Size: KB	Sep-13-2024	333-282104 241297943
8-K	Document	Current report filing Acc-no: 0001213900-24-077706 (34 Act) Size: KB	Sep-11-2024	000-53002 241292581

Recent 20 filings. View all Raphael Pharmaceutical Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Raphael Pharmaceutical Inc. overview
Raphael Pharmaceutical Inc. job
Raphael Pharmaceutical Inc. stock
Raphael Pharmaceutical Inc. ownership
Raphael Pharmaceutical Inc. CEO
Raphael Pharmaceutical Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.